Schiller Brigitte, Neitzer Andrea, Doss Sheila
Satellite Healthcare, USA.
Nephrol News Issues. 2010 Sep;24(10):36, 38, 40 passim.
Usage of renal replacement modalities available for the treatment of end stage renal disease varies widely between countries, indicating that non-medical factors contribute to the choice of therapy. In the United States, 93% of the patients are treated with in-center hemodialysis (HD), about 7% undergo peritoneal dialysis (PD) and less than 1% are on home HD. In comparison, a Northern California-based nonprofit dialysis provider with home dialysis centers throughout the United States has achieved a home therapy penetration of 22%, the highest proportion of home therapies among U.S. dialysis providers. To better understand the perceptions about the various modality choices among caretakers (nephrologists and nurses) in this organization a short questionnaire was used. We examined the hypothetical setting of the caretakers being in the patient role. More than 90% of the nephrology professionals chose a home therapy as initial treatment option with close to equal distribution between PD and home HD. This pattern persisted for maintenance therapy with home HD being the preferred modality. Nephrologists' and nurses' perception of who makes modality decisions varied profoundly.
终末期肾病的可用肾脏替代治疗方式在各国的使用情况差异很大,这表明非医学因素会影响治疗方式的选择。在美国,93%的患者接受中心血液透析(HD)治疗,约7%的患者进行腹膜透析(PD),不到1%的患者接受家庭血液透析。相比之下,一家总部位于北加利福尼亚、在美国各地设有家庭透析中心的非营利性透析服务提供商,其家庭治疗的渗透率达到了22%,是美国透析服务提供商中家庭治疗比例最高的。为了更好地了解该机构中护理人员(肾病学家和护士)对各种治疗方式选择的看法,我们使用了一份简短的问卷。我们研究了护理人员处于患者角色的假设情况。超过90%的肾病专业人员选择家庭治疗作为初始治疗方案,腹膜透析和家庭血液透析的分布接近相等。这种模式在维持治疗中持续存在,家庭血液透析是首选方式。肾病学家和护士对谁做出治疗方式决策的看法差异很大。